Lichen Amyloidosis Successfully Treated with Dupilumab
- Author:
Taeyeong KIM
1
;
Yeona KIM
;
Sang-Hyeon WON
;
Jungsoo LEE
;
Kihyuk SHIN
;
Hoon-Soo KIM
;
Byungsoo KIM
;
Moon-Bum KIM
;
Hyun-Chang KO
Author Information
1. Department of Dermatology, Pusan National University School of Medicine, Busan, Korea
- Publication Type:Case Report
- From:Korean Journal of Dermatology
2025;63(2):52-55
- CountryRepublic of Korea
- Language:English
-
Abstract:
Lichen amyloidosis is characterized by coalescent hyperpigmented papules with a predilection for the extremities and is accompanied by severe chronic pruritus. Various therapies have been attempted; however, there is no uniformly recognized effective treatment. In the first case, a 60-year-old man with a 37-year history of intractable itching presented with hyperkeratotic brown papules and coalescing plaques on the trunk and extensor surfaces of the extremities. The second case involved a 31-year-old man who presented with brownish macules and papules with a rippled pattern on the upper back and lower extremities. Histological examination of the lesions from both patients revealed epidermal hyperplasia and amorphous material deposited in the papillary dermis, which tested positive on Congo red staining. Although both patients were diagnosed with lichen amyloidosis, several treatment modalities showed limited efficacy. Subsequently, dupilumab, a treatment for severe pruritus, was administered to both patients, resulting in significant improvements.
